Abstract
A double-blind crossover trial was conducted of thyrotropin releasing hormone treatment in six patients with amyotrophic lateral sclerosis. Patients received 4 mg of thyrotropin releasing hormone intramuscularly daily during the two-week treatment period. Although three patients reported subjective improvement, objective evaluation failed to demonstrate therapeutic effectiveness of thyrotropin releasing hormone in this dosage.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cooper B. R., Boyer C. E. Stimulant action of thyrotropin releasing hormone on cat spinal cord. Neuropharmacology. 1978 Feb;17(2):153–156. doi: 10.1016/0028-3908(78)90128-4. [DOI] [PubMed] [Google Scholar]
- Engel W. K., Siddique T., Nicoloff J. T. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone. Lancet. 1983 Jul 9;2(8341):73–75. doi: 10.1016/s0140-6736(83)90060-0. [DOI] [PubMed] [Google Scholar]
- Hökfelt T., Fuxe K., Johansson O., Jeffcoate S., White N. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol. 1975 Dec;34(2):389–392. doi: 10.1016/0014-2999(75)90269-1. [DOI] [PubMed] [Google Scholar]
- Kardon F. C., Winokur A., Utiger R. D. Thyrotropin-releasing hormone (TRH) in rat spinal cord. Brain Res. 1977 Feb 25;122(3):578–581. doi: 10.1016/0006-8993(77)90471-1. [DOI] [PubMed] [Google Scholar]
- Sobue I., Takayanagi T., Nakanishi T., Tsubaki T., Uono M., Kinoshita M., Igata A., Miyazaki M., Yoshida M., Ando K. Controlled trial of thyrotropin releasing hormone tartrate in ataxia of spinocerebellar degenerations. J Neurol Sci. 1983 Oct;61(2):235–248. doi: 10.1016/0022-510x(83)90008-4. [DOI] [PubMed] [Google Scholar]
- Winokur A., Utiger R. D. Thyrotropin-releasing hormone: regional distribution in rat brain. Science. 1974 Jul 19;185(4147):265–267. doi: 10.1126/science.185.4147.265. [DOI] [PubMed] [Google Scholar]